Stryker Pushes For Changes To Stroke Care After DAWN

Stryker's Trevo Retriever is the first stent retriever approved by US FDA as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, matching the time window recommended in the latest professional treatment guidelines. Now, the company is trying to help the stroke-care system in the US catch up to the science.

Stryker Trevo Retreiver

Stryker Corp. wants to be a leader in changing how acute stroke is treated in the US, moving it from a time-based approach to determine which patients can be treated with thrombectomy, to a physiology-based strategy that the company says will bring more effective therapy to more patients.

US FDA recently approved new labeling for Stryker’s Trevo Retriever thrombectomy device, indicating it as front-line treatment for acute ischemic...

More from Approvals

More from Policy & Regulation